{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:43:16Z","timestamp":1787020996155,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Province Key R&D and Promotion","award":["182102310226"],"award-info":[{"award-number":["182102310226"]}]},{"name":"Henan Province Medical Science and Technology Joint construction Project","award":["LHGJ20190711"],"award-info":[{"award-number":["LHGJ20190711"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2302003"],"award-info":[{"award-number":["2021YFC2302003"]}]},{"name":"Natural Science Foundation of Beijing","award":["L192014"],"award-info":[{"award-number":["L192014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vaccine-derived poliovirus (VDPV) is a potential threat to polio eradication because they can reintroduce into the general population and cause paralytic polio outbreaks, a phenomenon that has recently emerged as a prominent public health concern at the end of global polio eradication. This study aimed to describe the epidemiology and genetic characteristics of the first VDPV identified from a patient with acute flaccid paralysis (AFP), with four doses of inactivated polio vaccine immunization in Henan Province, China in 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The patient was diagnosed with type 3 VDPV. Subsequently, a series of epidemiological approaches was implemented, including a retrospective search of AFP cases, rate of vaccination assessment, study of contacts, and supplementary immunization activities. Fecal samples were collected, viral isolation was performed, and the viral isolates were characterized using full-length genomic sequencing and bioinformatic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Phylogenetic analysis showed that the viral isolates from the patient were different from other reported genetic clusters of type 3 VDPV worldwide. They were identified as a Sabin 3\/Sabin 1 recombinant VDPV with a crossover site in the\n                      <jats:italic>P2<\/jats:italic>\n                      region. Nucleotide substitutions, including U\u2009\u2192\u2009C (472) and C\u2009\u2192\u2009U (2493), have been identified, both of which are frequently observed as reversion mutations in neurovirulent type 3 poliovirus. A unique aspect of this case is that the patient had been vaccinated with four doses of inactive polio vaccine, and the serum neutralizing antibody for Sabin types 1 and 3 were 1\u223616 and 1\u2236512, respectively. Thus, the patient was speculated to have been infected with type 3 VDPV, and the virus continued to replicate and be excreted for at least 41 d.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The existence of this kind of virus in human population is a serious risk and poses a severe challenge in maintaining a polio-free status in China. To the best of our knowledge, this is the first report of VDPV identified in the Henan province of China. Our results highlight the importance of maintaining a high-level vaccination rate and highly sensitive AFP case surveillance system in intercepting VDPV transmission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40249-022-01028-1","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T23:33:54Z","timestamp":1670974434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China"],"prefix":"10.1186","volume":"11","author":[{"given":"Mingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-5437","authenticated-orcid":false,"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"1028_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587\u2013635.","journal-title":"Annu Rev Microbiol"},{"key":"1028_CR2","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa1303368","volume":"369","author":"HM Luo","year":"2013","unstructured":"Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, et al. Identification and control of a poliomyelitis outbreak in Xinjiang. China N Engl J Med. 2013;369:1981\u201390.","journal-title":"China N Engl J Med"},{"issue":"Suppl 1","key":"1028_CR3","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","volume":"210","author":"CC Burns","year":"2014","unstructured":"Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283\u201393.","journal-title":"J Infect Dis"},{"key":"1028_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bsheal.2019.12.002","volume":"1","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhu S, Yan D, Wang D, Li X, Zhu H, et al. Type I vaccine-derived polioviruses in China from 1995 to 2019. Biosafety and Health. 2019;1:155\u20138.","journal-title":"Biosafety and Health"},{"key":"1028_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/v12070706","volume":"12","author":"L Brouwer","year":"2020","unstructured":"Brouwer L, Benschop KSM, Nguyen D, Kamau E, Pajkrt D, Simmonds P, et al. Recombination analysis of non-poliovirus members of the enterovirus c species; restriction of recombination events to members of the same 3DPol cluster. Viruses. 2020;12:706.","journal-title":"Viruses"},{"key":"1028_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chom.2020.10.011","volume":"29","author":"AL Valesano","year":"2021","unstructured":"Valesano AL, Taniuchi M, Fitzsimmons WJ, Islam MO, Ahmed T, Zaman K, et al. The early evolution of oral poliovirus vaccine is shaped by strong positive selection and tight transmission bottlenecks. Cell Host Microbe. 2021;29:32\u201343.","journal-title":"Cell Host Microbe"},{"key":"1028_CR7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/v13071407","volume":"13","author":"K Kitamura","year":"2021","unstructured":"Kitamura K, Shimizu H. The molecular evolution of type 2 vaccine-derived polioviruses in individuals with primary immunodeficiency diseases. Viruses. 2021;13:1403.","journal-title":"Viruses"},{"key":"1028_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0031-3955(05)70208-X","volume":"47","author":"RW Sutter","year":"2000","unstructured":"Sutter RW, Prevots DR, Cochi SL. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Pediatr Clin North Am. 2000;47:287\u2013308.","journal-title":"Pediatr Clin North Am."},{"key":"1028_CR9","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1128\/JVI.00277-16","volume":"90","author":"EA Korotkova","year":"2016","unstructured":"Korotkova EA, Gmyl AP, Yakovenko ML, Ivanova OE, Eremeeva TP, Kozlovskaya LI, et al. A cluster of paralytic poliomyelitis cases due to transmission of slightly diverged sabin 2 vaccine poliovirus. J Virol. 2016;90:5978\u201388.","journal-title":"J Virol"},{"key":"1028_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12992-020-00594-z","volume":"16","author":"LC Ming","year":"2020","unstructured":"Ming LC, Hussain Z, Yeoh SF, Koh D, Lee KS. Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication. Global Health. 2020;16:63.","journal-title":"Global Health"},{"key":"1028_CR11","doi-asserted-by":"publisher","first-page":"ofab535","DOI":"10.1093\/ofid\/ofab535","volume":"8","author":"H Zhao","year":"2021","unstructured":"Zhao H, Ma X, Tang H, Zhang Y, Chen N, Kaisaier W, et al. Circulation of type 2 vaccine-derived poliovirus in China in 2018\u20132019. Open Forum Infect Dis. 2021;8:ofab535.","journal-title":"Open Forum Infect Dis"},{"key":"1028_CR12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/v12090970","volume":"12","author":"EA Korotkova","year":"2020","unstructured":"Korotkova EA, Prostova MA, Gmyl AP, Kozlovskaya LI, Eremeeva TP, Baikova OY, et al. Case of poliomyelitis caused by significantly diverged derivative of the poliovirus type 3 vaccine sabin strain circulating in the orphanage. Viruses. 2020;12:970.","journal-title":"Viruses"},{"key":"1028_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.15585\/mmwr.mm6928a4","volume":"69","author":"G Macklin","year":"2020","unstructured":"Macklin G, Diop OM, Humayun A, Shahmahmoodi S, El-Sayed ZA, Triki H, et al. Update on immunodeficiency-associated vaccine-derived polioviruses\u2014worldwide, July 2018-December 2019. Morb Mortal Wkly Rep. 2020;69:913\u20137.","journal-title":"Morb Mortal Wkly Rep"},{"key":"1028_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","volume":"33","author":"J Guo","year":"2015","unstructured":"Guo J, Bolivar-Wagers S, Srinivas N, Holubar M, Maldonado Y. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication. Vaccine. 2015;33:1235\u201342.","journal-title":"Vaccine"},{"key":"1028_CR15","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1086\/657410","volume":"202","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Yan D, Zhu S, Wen N, Li L, Wang H, et al. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission. J Infect Dis. 2010;202:1780\u20138.","journal-title":"J Infect Dis"},{"key":"1028_CR16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s12879-017-2849-z","volume":"17","author":"HB Wang","year":"2017","unstructured":"Wang HB, Luo HM, Li L, Fan CX, Hao LX, Ma C, et al. Vaccine-derived poliovirus surveillance in China during 2001\u20132013: the potential challenge for maintaining polio free status. BMC Infect Dis. 2017;17:742.","journal-title":"BMC Infect Dis"},{"key":"1028_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-4939-3292-4_10","volume":"1387","author":"W Xu","year":"2016","unstructured":"Xu W, Zhang Y. Isolation and characterization of vaccine-derived polioviruses, relevance for the global polio eradication initiative. Methods Mol Biol. 2016;1387:213\u201326.","journal-title":"Methods Mol Biol"},{"key":"1028_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4939-3292-4_9","volume":"1387","author":"CC Burns","year":"2016","unstructured":"Burns CC, Kilpatrick DR, Iber JC, Chen Q, Kew OM. Molecular properties of poliovirus isolates: nucleotide sequence analysis, typing by PCR and real-time RT-PCR. Methods Mol Biol. 2016;1387:177\u2013212.","journal-title":"Methods Mol Biol"},{"key":"1028_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083975","volume":"8","author":"Z Tao","year":"2013","unstructured":"Tao Z, Zhang Y, Liu Y, Xu A, Lin X, Yoshida H, et al. Isolation and characterization of a type 2 vaccine-derived poliovirus from environmental surveillance in China, 2012. PLoS ONE. 2013;8: e83975.","journal-title":"PLoS ONE"},{"key":"1028_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255795","volume":"16","author":"H Sun","year":"2021","unstructured":"Sun H, Harrington C, Gerloff N, Mandelbaum M, Jeffries-Miles S, Apostol LNG, et al. Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network. PLoS ONE. 2021;16: e0255795.","journal-title":"PLoS ONE"},{"key":"1028_CR21","doi-asserted-by":"publisher","first-page":"17291","DOI":"10.1038\/srep17291","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yan D, Zhu S, Nishimura Y, Ye X, Wang D, et al. An insight into recombination with enterovirus species C and nucleotide G-480 reversion from the viewpoint of neurovirulence of vaccine-derived polioviruses. Sci Rep. 2015;5:17291.","journal-title":"Sci Rep"},{"key":"1028_CR22","doi-asserted-by":"publisher","first-page":"8366","DOI":"10.1128\/JVI.77.15.8366-8377.2003","volume":"77","author":"CF Yang","year":"2003","unstructured":"Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003;77:8366\u201377.","journal-title":"J Virol"},{"key":"1028_CR23","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022\u20137.","journal-title":"Mol Biol Evol"},{"key":"1028_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.virusres.2008.07.006","volume":"137","author":"S Shahmahmoodi","year":"2008","unstructured":"Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H, et al. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res. 2008;137:168\u201372.","journal-title":"Virus Res"},{"key":"1028_CR25","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.010942-0","author":"C Savolainen-Kopra","year":"2009","unstructured":"Savolainen-Kopra C, Samoilovich E, Kahelin H, Hiekka AK, Hovi T, Roivainen M. Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages. J Gen Virol. 2009. https:\/\/doi.org\/10.1099\/vir.0.010942-0.","journal-title":"J Gen Virol."},{"key":"1028_CR26","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3201\/eid2110.150702","volume":"21","author":"DK Sharma","year":"2015","unstructured":"Sharma DK, Nalavade UP, Varose SY, Deshpande JM. Vaccine-derived polioviruses not detected by global surveillance screening assay. Emerg Infect Dis. 2015;21:1880\u20131.","journal-title":"Emerg Infect Dis"},{"key":"1028_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nmeth.2109","volume":"9","author":"D Darriba","year":"2012","unstructured":"Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 2012;9:772.","journal-title":"Nat Methods"},{"key":"1028_CR28","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/bioinformatics\/btu033","volume":"30","author":"A Stamatakis","year":"2014","unstructured":"Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30:1312\u20133.","journal-title":"Bioinformatics"},{"key":"1028_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","volume":"73","author":"KS Lole","year":"1999","unstructured":"Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152\u201360.","journal-title":"J Virol"},{"key":"1028_CR30","doi-asserted-by":"publisher","first-page":"15471","DOI":"10.1074\/jbc.RA118.004913","volume":"293","author":"BC Avanzino","year":"2018","unstructured":"Avanzino BC, Jue H, Miller CM, Cheung E, Fuchs G, Fraser CS. Molecular mechanism of poliovirus Sabin vaccine strain attenuation. J Biol Chem. 2018;293:15471\u201382.","journal-title":"J Biol Chem"},{"key":"1028_CR31","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1128\/JVI.02954-12","volume":"87","author":"CC Burns","year":"2013","unstructured":"Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013;87:4907\u201322.","journal-title":"J Virol"},{"key":"1028_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/infdis\/jiaa386","volume":"223","author":"D Yan","year":"2021","unstructured":"Yan D, Wang D, Zhang Y, Li X, Tang H, Guan J, et al. Implication of a high risk for type 2 vaccine-derived poliovirus emergence and transmission after the switch from trivalent to bivalent oral poliovirus vaccine. J Infect Dis. 2021;223:113\u20138.","journal-title":"J Infect Dis"},{"key":"1028_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6201","volume":"367","author":"O Dyer","year":"2019","unstructured":"Dyer O. Polio: WHO declares type 3 poliovirus eradicated after 31 year campaign. BMJ. 2019;367: l6201.","journal-title":"BMJ"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-022-01028-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T23:35:53Z","timestamp":1670974553000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-022-01028-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1186\/s40249-022-01028-1","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of the Henan Center for Disease Control and Prevention (CDC) Institutional Review Board (Approval Number: IVDC2016-004). Written informed consent regarding anonymizing the publication of VDPV infection and the use of clinical samples was obtained from the parents of the children involved in this study. All experimental protocols were approved by the Henan CDC, and the study were performed in accordance with the approved guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}